S O'Sullivan1, L Cormican, C M Burke, L W Poulter. 1. Department of Immunology, Royal Free and University College Hospital Medical School, London NW3 2QG, UK. sioosu@indigo.ie
Abstract
BACKGROUND: Cytokines which signal via the gamma chain of the interleukin (IL)-2 receptor and the interferons (IFNs) have been shown to enhance T cell survival in vitro by rescuing cells from apoptosis. METHODS: A study was undertaken to determine whether treatment with inhaled fluticasone propionate (FP; 250 microg twice daily) for 2 weeks could modulate production of IL-15 or IFN-beta and thereby affect T cell survival in bronchial tissue of 10 patients with mild/moderate asthma. Bronchial biopsy specimens were taken before and on completion of treatment. RESULTS: The mean (95% CI) number of T cells per unit area decreased in the asthmatic group following 2 weeks of treatment with FP (from 7.0 (5.6 to 8.4) to 4.5 (4.0 to 5.1); p = 0.001). There was an increase in the percentage of T cells undergoing apoptosis following FP treatment as assessed by T cell/TUNEL staining (from 4.5 (2.6 to 6.4) to 8.7 (6.6 to 10.8); p = 0.0001). The percentage of cells staining for IL-15 and IFN-beta in the lamina propria, determined by an alkaline phosphatase biotin streptavidin technique, decreased significantly from baseline values of 31.6 (23.4 to 39.7) to 19.6 (12.5 to 26.7), p = 0.039 for IL-15 and from 18.9 (13.5 to 24.4) to 9.5 (5.9 to 13.1), p = 0.007 for IFN-beta following 2 weeks of treatment with FP. However, only the decrease in the percentage of cells staining for IL-15 was significantly correlated with an increased number of apoptotic T cells following treatment (p = 0.008). CONCLUSION: These findings support a novel mechanism for the ability of inhaled corticosteroids to decrease T cell numbers, possibly by downregulation of the cytokine IL-15.
BACKGROUND: Cytokines which signal via the gamma chain of the interleukin (IL)-2 receptor and the interferons (IFNs) have been shown to enhance T cell survival in vitro by rescuing cells from apoptosis. METHODS: A study was undertaken to determine whether treatment with inhaled fluticasone propionate (FP; 250 microg twice daily) for 2 weeks could modulate production of IL-15 or IFN-beta and thereby affect T cell survival in bronchial tissue of 10 patients with mild/moderate asthma. Bronchial biopsy specimens were taken before and on completion of treatment. RESULTS: The mean (95% CI) number of T cells per unit area decreased in the asthmatic group following 2 weeks of treatment with FP (from 7.0 (5.6 to 8.4) to 4.5 (4.0 to 5.1); p = 0.001). There was an increase in the percentage of T cells undergoing apoptosis following FP treatment as assessed by T cell/TUNEL staining (from 4.5 (2.6 to 6.4) to 8.7 (6.6 to 10.8); p = 0.0001). The percentage of cells staining for IL-15 and IFN-beta in the lamina propria, determined by an alkaline phosphatase biotin streptavidin technique, decreased significantly from baseline values of 31.6 (23.4 to 39.7) to 19.6 (12.5 to 26.7), p = 0.039 for IL-15 and from 18.9 (13.5 to 24.4) to 9.5 (5.9 to 13.1), p = 0.007 for IFN-beta following 2 weeks of treatment with FP. However, only the decrease in the percentage of cells staining for IL-15 was significantly correlated with an increased number of apoptotic T cells following treatment (p = 0.008). CONCLUSION: These findings support a novel mechanism for the ability of inhaled corticosteroids to decrease T cell numbers, possibly by downregulation of the cytokine IL-15.
Authors: D Pilling; A N Akbar; J Girdlestone; C H Orteu; N J Borthwick; N Amft; D Scheel-Toellner; C D Buckley; M Salmon Journal: Eur J Immunol Date: 1999-03 Impact factor: 5.532
Authors: F Spinozzi; M Fizzotti; E Agea; S Piattoni; S Droetto; A Russano; N Forenza; G Bassotti; F Grignani; A Bertotto Journal: Ann Intern Med Date: 1998-03-01 Impact factor: 25.391
Authors: A M Vignola; P Chanez; G Chiappara; L Siena; A Merendino; C Reina; R Gagliardo; M Profita; J Bousquet; G Bonsignore Journal: J Allergy Clin Immunol Date: 1999-04 Impact factor: 10.793
Authors: A Druilhe; B Wallaert; A Tsicopoulos; J R Lapa e Silva; I Tillie-Leblond; A B Tonnel; M Pretolani Journal: Am J Respir Cell Mol Biol Date: 1998-11 Impact factor: 6.914
Authors: K L Woolley; P G Gibson; K Carty; A J Wilson; S H Twaddell; M J Woolley Journal: Am J Respir Crit Care Med Date: 1996-07 Impact factor: 21.405
Authors: Elena A Goncharova; Poay N Lim; Amelia Chisolm; Homer W Fogle; Jerome H Taylor; Dmitry A Goncharov; Andrew Eszterhas; Reynold A Panettieri; Vera P Krymskaya Journal: Am J Physiol Lung Cell Mol Physiol Date: 2010-04-09 Impact factor: 5.464
Authors: Gaetano Caramori; David Groneberg; Kazuhiro Ito; Paolo Casolari; Ian M Adcock; Alberto Papi Journal: J Occup Med Toxicol Date: 2008-02-27 Impact factor: 2.646